JASMINE COFIELD: Open Payments
NPI 1487248795 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 10 payments from 6 companies in 2025. Trend: 2023 $364 · 2024 $660 · 2025 $547
Food & beverage: $432Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $155 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| AstraZeneca Pharmaceuticals LP | 2 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $65 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: REXULTI, SPRAVATO, CAPLYTA, Kerendia, Qelbree.
Industry payments across MI — which companies pay providers there.
